This article by the Centre for the AIDS Programme of Research in South Africa summarises the results of the CAPRISA 004 trial that assessed effectiveness and safety of a 1% vaginal gel formulation of tenofovir, a nucleotide reverse transcriptase inhibitor, for the prevention of HIV acquisition in women. The vaginal gel has significantly cut infection rates among 889 women by 50% after one year of ...
IRMA's new report, From Product to Promise - Advancing Rectal Microbicide Research and Advocacy, officially released at the Microbicides 2010 conference in Pittsburgh on May 23, 2010, provides an overview of the maturing rectal microbicide field, updates the resource tracking exercise IRMA last conducted in 2006, and lays out global advocacy goals and objectives.
Importantly, the report also c...
PITTSBURGH, May 17 – Issues on the forefront of HIV prevention research will be taking center stage at the International Microbicides Conference (M2010) at the David L. Lawrence Convention Center in Pittsburgh May 22-25. M2010 will be a gathering of leading investigators, clinicians, policy makers, community advocates and experts in global health who are working in all facets of HIV prevention and...
Aidsmap
This link is Aidsmap's web section on Microbicides summarising the latest research on mircrobicides worldwide.
...
The global need to expand prevention efforts to reduce the spread of HIV & AIDS is greater today than ever before, especially in sub-Saharan African, which carries the brunt of the infection with over 60% of the world's HIV & AIDS infected people. In addition, more than 50% of people living with HIV globally are women - their protection in particular should be prioritised. One possible method of p...
« Back to subject page